JUNIPER PHARMACEUTICALS INC Deferred Revenue, Additions
JUNIPER PHARMACEUTICALS INC reported Deferred Revenue, Additions of $1.22 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Income Statement › Other Income
us-gaap:DeferredRevenueAdditions · last filed 2018-08-09
- JUNIPER PHARMACEUTICALS INC deferred revenue, additions for the quarter ending 2018-06-30 was $691.00K.
- JUNIPER PHARMACEUTICALS INC deferred revenue, additions for the quarter ending 2018-03-31 was $526.00K.
| Period end | Deferred Revenue, Additions 3 month | Deferred Revenue, Additions 6 month |
|---|---|---|
| 2018-06-30 | $691.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $1.22M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $526.00K 10-Q · filed 2018-05-10 |